文献速递妇科

医疗补助扩展对宫颈癌筛查的影响:一项州特异性双重差分分析

Impact of medicaid expansion on cervical cancer screening: A state-specific difference in difference analysis.
PubMed 文献 · Gynecol Oncol · 2024-07-15

总体双重差分显示扩展州筛查增加比非扩展州高1.1个百分点(95%CI:0.1至2.0%,P=0.03)。

要点

  • 医疗补助扩展州宫颈癌筛查增加比非扩展州高1.1个百分点(95%CI:0.1至2.0%,P=0.03)。
  • 6个扩展州筛查增加显著高于非扩展州:俄勒冈州8.5%、肯塔基州4.5%、华盛顿州4.2%、科罗拉多州4.3%、内华达州4.7%、俄亥俄州2.8%。
  • 上述6州中5个属于基线筛查率最低的州,基线筛查率较低的扩展州扩展后筛查增加更大。

核心结论

  • 医疗补助扩展州宫颈癌筛查增加相对非扩展州更大;基线筛查率较低的扩展州扩展后筛查增加更大。

研究设计与样本

  • 以2010年和2012年为扩展前时期,2016年和2018年为扩展后时期。
  • 采用双重差分分析比较扩展州与非扩展州宫颈癌筛查变化,并对每个扩展州单独分析。

主要发现

  • 总体双重差分显示扩展州宫颈癌筛查增加比非扩展州高1.1个百分点(95%CI:0.1至2.0%,P=0.03)。
  • 与非扩展州相比,6个扩展州筛查增加显著更高:俄勒冈州8.5%(P<0.001)、肯塔基州4.5%(P=0.001)、华盛顿州4.2%(P=0.002)、科罗拉多州4.3%(P=0.008)、内华达州4.7%(P=0.048)、俄亥俄州2.8%(P=0.03)。
  • 上述6个州中5个属于基线筛查率最低的州。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: In 2014 the Affordable Care Act expanded Medicaid coverage in states that opted to participate. Limited data are available describing the effect of Medicaid expansion on cancer screening. The objective of our study was to evaluate trends in cervical cancer screening associated with Medicaid expansion. METHODS: Using data from the Behavioral Risk Factor Surveillance System, we identified female respondents ages 30-64 years with a household income below $35,000. The outcome measure was guideline-adherent cervical cancer screening. The years 2010 and 2012 constituted the pre-expansion period while 2016 and 2018 were used to capture the post-expansion period. A difference-in-difference (DID) analysis was performed to assess changes in cervical cancer screening in Medicaid expansion states compared to non-expansion states, for the overall sample and for each expansion state individually. RESULTS: The overall DID analysis showed a greater increase in cervical cancer screening by 1.1 percentage points (95% CI: 0.1 to 2.0%, P = 0.03) in expansion states compared to non-expansion states. The analysis comparing individual expansion states to non-expansion states showed that 6 expansion states had a significantly higher increase in screening relative to non-expansion states: Oregon (8.5%, P < 0.001), Kentucky (4.5%, P = 0.001), Washington (4.2%, P = 0.002), Colorado (4.3%, P = 0.008), Nevada (4.7%, P = 0.048), and Ohio (2.8%, P = 0.03). Of these states, 5 ranked among the states with the lowest baseline screening rates. CONCLUSIONS: Medicaid expansion states experienced a greater increase in cervical cancer screening relative to non-expansion states. Expansion states with lower baseline screening rates experienced greater increases in screening after expanding Medicaid.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Bergstein A, Huang Y, Hershman DL, et al. Impact of medicaid expansion on cervical cancer screening: A state-specific difference in difference analysis. Gynecol Oncol. 2024. PMID: 39013240. doi:10.1016/j.ygyno.2024.06.028

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。